Axxess Pharma Inc. Announces MOU to Acquire Leading Canadian OTC Healthcare Company
03 September 2013 - 6:15AM
Marketwired
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical
and nutritional supplements company, today announced an Agreement
in Principle to acquire a leading Canadian OTC healthcare company.
Upon completion of the acquisition, the company will bring current
sales and a valuable IP portfolio to Axxess Pharma.
The Canadian Corporation, based in Toronto, has an attractive IP
portfolio including a best-selling, patented, OTC pain relief
formula. The company also has a number of unique formulas and world
class brand products that Axxess Pharma will be able to immediately
leverage, with existing distribution.
The company will also bring a number of experienced executives
to Axxess Pharma to assist in growing sales across North America,
and online.
Dr. Bagi, President of Axxess Pharma Inc. stated, "We anticipate
completing the final agreement within 30 days. This acquisition
will facilitate access to capital and generate a rapid ramp-up of
sales. We anticipate major revenue growth in the near term with
this aquisition."
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, - to optimal health management through
improved nutritional supplements.
Safe Harbor Statement:
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 STEPHTAYL9@AOL.COM www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024